PFNLive
- Wall Street Posts Worst Day Since November 7 on Gold's Drop, Boston Blasts
- Gold Set for Worst 2-Day Rout in 30 Years, Stocks Drop
- Theravance Rallies after FDA's Mixed Breo Briefing
- Wall Street Tumbles, Major Indexes off More than 1 Percent
- U.S. Justices Decline to Hear Glaxo Appeal over Avandia
- Sanofi CEO Fires Surprise Torpedo at Alzheimer's Drug Research
- Royalty Pharma Raises Elan Bid to as Much as $7.3 Billion
- Wall Street Falls as Data Triggers Slowdown Worry
- Thermo Fisher to Buy Life Technologies for $11.4 Billion
- Roche in Hepatitis C Drug Deal with Ascletis in China
- Wall Street Ends Down but Indexes Notch Sharp Weekly Gains
- Stocks End a Four-Day Advance as Energy Slides
- Glaxo’s Avandia Gets Second Look at Heart Risk by U.S.
- Drugmaker Eli Lilly to Cut 1,000 U.S. Sales Jobs
- Wall Street Adds to Losses after Sentiment Data
- Bristol-Myers, Lilly Expand Biologics Operations
- Wall Street to Open Weaker on Retail Sales, Banks Dip
- Valeant, Actavis Team up on Two More Authorized Generics
- Acadia Gets Expedited FDA Review Path for Lead Drug
- Grifols Jumps as Exane Expects Increase in Plasma Pricing
